To assess the effects of Enigma and Cbl-c expression on outcomes in patients whose tumors express RET, we combined two publicly available breast cancer datasets for which RET, Cbl-c and Enigma expression and outcome data were available [27], [28]. This evidence concerns the gene CBLC and breast cancer.